Cytyc’s Purchase Of Adiana Opens Door To Female Contraception Market
This article was originally published in The Gray Sheet
Executive Summary
Cytyc could gain PMA approval by year-end for its newly acquired, non-incisional alternative to tubal ligation for permanent female contraception, according to the company